Press releases archive

Neorphys closes its 1st financing round.

A first financing round of 1.05 M€ has been achieved in 2007 with Inserm Transfert Initiative, Soridec and CEA Valorisation (VCs). It will be used to pursue the development of the analgesic drug candidate up to the start of regulatory preclinical studies and to make possible an animal assay for Neorphys second therapeutic axis, female sexual dysfunction.
Download press release - pdf (56kb)
Télécharger le communiqué - pdf (49kb)